ClinicalTrials.Veeva

Menu

Conventional With Stereotactic Radiotherapy for Pain Reduction and Quality of Life in Spinal Metastases (RACOST)

R

Radboud University Medical Center

Status

Terminated

Conditions

Spinal Metastases

Treatments

Radiation: conventional radiotherapy
Radiation: stereotactic radiotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT02407795
NL45994.091.14

Details and patient eligibility

About

A randomized, multicentre, phase III study comparing conventional radiotherapy (1x8Gy) with stereotactic radiotherapy (1x20Gy) for pain reduction and quality of life in spinal metastases.

Full description

Study population: patients with painful spinal metastases from solid tumors without spinal cord compression or cord instability.

Objective: This study will test the hypothesis that stereotactic radiotherapy gives a better and longer lasting reduction of pain, local control and therewith a better quality of life. This in order to optimize and to individualize the treatment options for the patient.

Study design: Complaints due to pain will be analysed using the validated Dutch Brief Pain Inventory (BPI) and side-effects will be recorded using the Common Toxicity Criteria for Adverse Events (CTCAE). In addition to this the quality of life will be analysed using the EORTC QOL-C15-PAL and EORTC QLQ-BM22 questionnaires. For analysis of cost-effectiveness the EQ-5D will be used.

Enrollment

25 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • solid tumor with radiological diagnosis of spinal metastases
  • pain score minimum 2 on 11-point scale
  • maximum of 2 consecutive or noncontiguous spinal vertebra involved by tumor at current level of interest
  • No or mild neurological signs (radiculopathy, dermatomal sensory change and muscle strength of involved extremity)
  • Karnofsky performance ≥60
  • WHO ≤2
  • life expectancy > 6 weeks
  • age ≥18
  • non-pregnant, non-lactating female patients

Exclusion criteria

  • history of previous radiotherapy to the spine at current level of interest
  • spinal instability or neurological deficit
  • pathological fracture or impending fracture needing fixation
  • prior surgery to the spine at current level of interest
  • clinical signs of spinal cord compression or severe neurological deficits
  • patients with a pacemaker such that MRI cannot be performed or the treatment cannot be delivered safely
  • patients unable to undergo MRI
  • earlier nuclear medicine treatment
  • pregnancy
  • altered mental status that would prohibit the understanding and giving of informed consent

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

25 participants in 2 patient groups

Arm 1
Active Comparator group
Description:
Conventional radiotherapy, 1x8Gy
Treatment:
Radiation: conventional radiotherapy
Arm 2
Experimental group
Description:
Stereotactic radiotherapy, 1x20Gy
Treatment:
Radiation: stereotactic radiotherapy

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems